This page shows anti-doping rule violation data we have registered for Triamcinolone.
Triamcinolone ranks #54 globally among prohibited substances, with 65 registered cases (0.4% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. Kenya leads with 17 cases, while Cycling is the most affected sport (27 cases).
Cycling has the most recorded cases of Triamcinolone violations globally, with 27 registered cases — 0% of all 65 verified cases.
Kenya leads significantly in Triamcinolone violations globally, with 17 registered cases — 26.2% of all 65 verified cases.
Triamcinolone ranks #54 of 358 prohibited substances in the Anti-Doping Database.
This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.
The average suspension for Triamcinolone violations is 28.6 months, aligned with the global average.
Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.
As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:
The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.